These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23045473)

  • 21. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
    Abbas S; Chang-Claude J; Linseisen J
    Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies.
    Ekmekcioglu C; Haluza D; Kundi M
    Int J Environ Res Public Health; 2017 Jan; 14(2):. PubMed ID: 28134804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
    Palmieri C; MacGregor T; Girgis S; Vigushin D
    J Clin Pathol; 2006 Dec; 59(12):1334-6. PubMed ID: 17046848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
    Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
    Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifestyle and Dietary Factors Associated with Serum 25-Hydroxyvitamin D Levels in Korean Young Adults.
    Joh HK; Lim CS; Cho B
    J Korean Med Sci; 2015 Aug; 30(8):1110-20. PubMed ID: 26240489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association?
    Lagunova Z; Porojnicu AC; Grant WB; Bruland Ø; Moan JE
    Mol Nutr Food Res; 2010 Aug; 54(8):1127-33. PubMed ID: 20512788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between plasma 25-hydroxyvitamin D and colorectal adenoma according to dietary calcium intake and vitamin D receptor polymorphism.
    Yamaji T; Iwasaki M; Sasazuki S; Sakamoto H; Yoshida T; Tsugane S
    Am J Epidemiol; 2012 Feb; 175(3):236-44. PubMed ID: 22193171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk.
    Touvier M; Chan DS; Lau R; Aune D; Vieira R; Greenwood DC; Kampman E; Riboli E; Hercberg S; Norat T
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1003-16. PubMed ID: 21378269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
    Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
    J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.
    Mohr SB; Gorham ED; Alcaraz JE; Kane CJ; Macera CA; Parsons JK; Wingard DL; Garland CF
    Anticancer Res; 2011 Sep; 31(9):2939-48. PubMed ID: 21868542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study.
    Jamshidinaeini Y; Akbari ME; Abdollahi M; Ajami M; Davoodi SH
    J Am Coll Nutr; 2016; 35(7):639-646. PubMed ID: 27331363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased preoperative serum 25-Hydroxyvitamin D levels in colorectal cancer are associated with systemic inflammation and serrated morphology.
    Väyrynen JP; Mutt SJ; Herzig KH; Väyrynen SA; Kantola T; Karhu T; Karttunen TJ; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A
    Sci Rep; 2016 Nov; 6():36519. PubMed ID: 27819306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.
    Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM
    J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies.
    Ma Y; Zhang P; Wang F; Yang J; Liu Z; Qin H
    J Clin Oncol; 2011 Oct; 29(28):3775-82. PubMed ID: 21876081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.
    Agborsangaya CB; Surcel HM; Toriola AT; Pukkala E; Parkkila S; Tuohimaa P; Lukanova A; Lehtinen M
    Eur J Cancer; 2010 Feb; 46(3):467-70. PubMed ID: 20022237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.
    Pazdiora P; Svobodova S; Fuchsova R; Kucera R; Prazakova M; Vrzalova J; Narsanska A; Strakova M; Treskova I; Pecen L; Treska V; Holubec L; Pesek M; Finek J; Topolcan O
    Anticancer Res; 2011 Oct; 31(10):3619-21. PubMed ID: 21965787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies.
    van der Rhee H; Coebergh JW; de Vries E
    Eur J Cancer; 2013 Apr; 49(6):1422-36. PubMed ID: 23237739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insufficient vitamin D supply as a possible co-factor in colorectal carcinogenesis.
    Sieg J; Sieg A; Dreyhaupt J; Schmidt-Gayk H
    Anticancer Res; 2006; 26(4A):2729-33. PubMed ID: 16886684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
    Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum.
    Mohr SB; Gorham ED; Alcaraz JE; Kane CI; Macera CA; Parsons JK; Wingard DL; Horst R; Garland CF
    Cancer Causes Control; 2013 Mar; 24(3):495-504. PubMed ID: 23296455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.